Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2023.1180076/full |
_version_ | 1797808877881786368 |
---|---|
author | Wenqi Wu Su Liu Linyan Tian Cheng Li Yanan Jiang Jinhuan Wang Yangyang Lv Jing Guo Donghui Xing Yixin Zhai Huimeng Sun Yuhang Li Luying Zhang Xiang He Kaiping Luo Hongjie Zhan Zhigang Zhao Zhigang Zhao |
author_facet | Wenqi Wu Su Liu Linyan Tian Cheng Li Yanan Jiang Jinhuan Wang Yangyang Lv Jing Guo Donghui Xing Yixin Zhai Huimeng Sun Yuhang Li Luying Zhang Xiang He Kaiping Luo Hongjie Zhan Zhigang Zhao Zhigang Zhao |
author_sort | Wenqi Wu |
collection | DOAJ |
first_indexed | 2024-03-13T06:44:13Z |
format | Article |
id | doaj.art-5b72d4122ac34840ad4388358a49299f |
institution | Directory Open Access Journal |
issn | 1664-8021 |
language | English |
last_indexed | 2024-03-13T06:44:13Z |
publishDate | 2023-06-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Genetics |
spelling | doaj.art-5b72d4122ac34840ad4388358a49299f2023-06-08T11:19:09ZengFrontiers Media S.A.Frontiers in Genetics1664-80212023-06-011410.3389/fgene.2023.11800761180076Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis predictionWenqi Wu0Su Liu1Linyan Tian2Cheng Li3Yanan Jiang4Jinhuan Wang5Yangyang Lv6Jing Guo7Donghui Xing8Yixin Zhai9Huimeng Sun10Yuhang Li11Luying Zhang12Xiang He13Kaiping Luo14Hongjie Zhan15Zhigang Zhao16Zhigang Zhao17Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Medical Oncology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Gastroenterology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Medical Oncology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, Chinahttps://www.frontiersin.org/articles/10.3389/fgene.2023.1180076/fullDLBCLmicrotube-associated genesprognostic modeltargeting therapyTMEM63A |
spellingShingle | Wenqi Wu Su Liu Linyan Tian Cheng Li Yanan Jiang Jinhuan Wang Yangyang Lv Jing Guo Donghui Xing Yixin Zhai Huimeng Sun Yuhang Li Luying Zhang Xiang He Kaiping Luo Hongjie Zhan Zhigang Zhao Zhigang Zhao Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction Frontiers in Genetics DLBCL microtube-associated genes prognostic model targeting therapy TMEM63A |
title | Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction |
title_full | Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction |
title_fullStr | Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction |
title_full_unstemmed | Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction |
title_short | Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction |
title_sort | corrigendum identification of microtube associated biomarkers in diffuse large b cell lymphoma and prognosis prediction |
topic | DLBCL microtube-associated genes prognostic model targeting therapy TMEM63A |
url | https://www.frontiersin.org/articles/10.3389/fgene.2023.1180076/full |
work_keys_str_mv | AT wenqiwu corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT suliu corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT linyantian corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT chengli corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT yananjiang corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT jinhuanwang corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT yangyanglv corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT jingguo corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT donghuixing corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT yixinzhai corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT huimengsun corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT yuhangli corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT luyingzhang corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT xianghe corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT kaipingluo corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT hongjiezhan corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT zhigangzhao corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction AT zhigangzhao corrigendumidentificationofmicrotubeassociatedbiomarkersindiffuselargebcelllymphomaandprognosisprediction |